首页 | 本学科首页   官方微博 | 高级检索  
     

组蛋白修饰与肝癌关系的研究进展
引用本文:张浩鹏,;畅建平,;杨艳梅,;张新宇. 组蛋白修饰与肝癌关系的研究进展[J]. 胃肠病学和肝病学杂志, 2014, 0(8): 862-865
作者姓名:张浩鹏,  畅建平,  杨艳梅,  张新宇
作者单位:[1]哈尔滨医科大学附属第二医院普通外科,黑龙江哈尔滨150086; [2]哈尔滨医科大学肿瘤防治研究所,黑龙江哈尔滨150086;
基金项目:国家自然科学基金资助项目(30972561)
摘    要:组蛋白修饰模式的异常能导致基因表达的改变,这在肝癌的发生、发展中起重要作用。组蛋白修饰酶相关抑制剂可以抑制修饰酶的活性,逆转肝癌细胞异常的组蛋白修饰模式,从而达到治疗肿瘤的目的。对组蛋白修饰、相关修饰酶及其抑制剂的进一步研究,不仅有助于深入了解肝癌的发病机制,而且对于肝癌的诊断、防治和预后判断均有深远影响。

关 键 词:组蛋白乙酰化  组蛋白甲基化  组蛋白去乙酰化酶抑制剂  组蛋白甲基转移酶抑制剂  肝癌

Relationship between histone modification and hepatocarcinoma
Affiliation:ZHANG Haopeng,CHANG , Jianping , YANG Yanmei, ZHANG Xinyu( 1. Department of General Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086; 2 Cancer Research Institute, Harbin Medical University, China)
Abstract:Abnormal histone modification patterns can lead to the changes of gene expression, and it plays a crucial role in the occurrence and development of hepatocarcinoma. To achieve the purpose of treatment of hepatocarcinoma, the inhibitors of histone modifying enzymes can inhibit the activity of modifying enzymes and reverse abnormal histone modi- fication patterns of hepatoearcinoma cells. The further study of histone modifications, relevant modifying enzymes and in- hibitors of relevant modifying enzymes not only helps deeply understand the pathogenesis of hepatocarcinoma, but also has an influence on diagnosis, prevention and prognosis of hepatocarcinoma.
Keywords:Histone acetylation  Histone methylation  Histone deacetylase inhibitors  Histone methyltransferase in-hibitors  Hepatocarcinoma
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号